A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.
|Articles|December 20, 2010
Supplements and Featured Publications
- Facing Type 2 Diabetes in the Healthcare Reform Era [CME/CPE]
- Volume 16
- Issue 11 Suppl
Facing Type 2 Diabetes in the Healthcare Reform Era
Advertisement
Articles in this issue
almost 16 years ago
SECTION 1: The Clinical Challenges of Diabetes Managementalmost 16 years ago
Participating Facultyalmost 16 years ago
Disclosuresalmost 16 years ago
Facing Type 2 Diabetes in the Healthcare Reform EraAdvertisement
Related to this article
The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in health care.
Incidence of diabetic macular edema and the need for glaucoma surgery were reduced after treatment with glucagon-like peptide-1 receptor agonists.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
TP53 mutations occurred in 3% of myeloproliferative neoplasms (MPNs) but 10% of myelofibrosis or blast-phase cohorts in a review of 11 cohort studies.
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
3
Keynote Address Tackles AI’s Role in Health Care, Eye Care
4
Full POLARGO Data Reveal OS, Safety for Pola-R-GemOx in DLBCL
5